Skip to content
sellModerate cluster of 4

Philip Mazzara sold $2.3M of ALAB

General Counsel and Secretary at Astera Labs, Inc.. 6,801 shares at an average of $340.50, traded Aug 17, 2026, filed Aug 19, 2026.

Warning score
55
Value
$2.3M
6,801 shares
Holdings after
96,542
-7% from before
From 52-week low
+219%
low $100.27, close $320.17
From 52-week high
-34%
high $483.02, as of Aug 17, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $2.3M at market
    +25
  • Share of holdings sold
    Sold 6.6% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ALABOct 9, 2026 · close 342.21
Since filing Aug 19, 2026: +18.4%SPY +1.4% · excess +17.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001998163-26-000022, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 17, 2026SOpen-market sale
Common Stock
-44$352.10$15k103,299Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-82$351.24$29k103,217Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-156$349.19$54k103,061Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-81$348.05$28k102,980Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-269$347.02$93k102,711Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-199$346.13$69k102,512Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-1,310$344.99$452k101,202Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-287$343.94$99k100,915Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-415$342.95$142k100,500Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-125$341.71$43k100,375Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-205$340.58$70k100,170Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-504$339.74$171k99,666Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-610$338.58$207k99,056Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-797$337.76$269k98,259Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-227$336.65$76k98,032Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-136$335.42$46k97,896Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-540$334.23$180k97,356Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock
-814$333.64$272k96,542Aug 19, 2026

Related signals

Other insiders at Astera Labs, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 16, 2026
ALABsell10b5-1
Astera Labs, Inc.
Stefan A Dyckerhoff
director
$4.7M
12,499 shares
-25%
33Weak
ALABsell 210b5-1
Astera Labs, Inc.
Manuel Alba
director
$51M
183,000 shares
-14%
33Weak
ALABsell 210b5-1
Astera Labs, Inc.
Stefan A Dyckerhoff
director
$3.4M
12,499 shares
-23%
65Notable
ALABsell 4
Astera Labs, Inc.
Jitendra Mohan
Chief Executive Officer
$31M
90,630 shares
-7%
60Notable
ALABsell 4
Astera Labs, Inc.
Sanjay Gajendra
President and COO
$31M
90,630 shares
-7%
40Moderate
ALABsell 410b5-1
Astera Labs, Inc.
Stefan A Dyckerhoff
director
$3.9M
12,499 shares
-22%
35Weak
ALABsell 310b5-1
Astera Labs, Inc.
Manuel Alba
director
$61M
136,974 shares
-10%
35Weak
ALABsell 310b5-1
Astera Labs, Inc.
Manuel Alba
director
$17M
37,535 shares
-3%
35Weak
ALABsell 310b5-1
Astera Labs, Inc.
Manuel Alba
director
$3.9M
8,491 shares
-3%
40Moderate
ALABsell 310b5-1
Astera Labs, Inc.
Stefan A Dyckerhoff
director
$5.6M
12,499 shares
-20%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.